Small Company Offering and Sale of Securities Without Registration (d)

o NoneEntity Type

0001534248

Anchiano Therapeutics Ltd.

BioCancell Ltd.

x Corporation

o Limited Partnership

o Limited Liability Company

o General Partnership

o Business Trust

o Other

Name of Issuer

Chemomab Therapeutics Ltd.

Jurisdiction of Incorporation/OrganizationISRAEL

Year of Incorporation/Organization
	x	Over Five Years Ago
	o	Within Last Five Years (Specify Year)
	o	Yet to Be Formed

2. Principal Place of Business and Contact Information
Name of Issuer
Chemomab Therapeutics Ltd.

Street Address 1		Street Address 2
KIRYAT ATIDIM, BUILDING 7

City	State/Province/Country	ZIP/Postal Code	Phone No. of Issuer
TEL AVIV	ISRAEL	6158002	+972-77-331-0156

3. Related Persons

Last Name	First Name	Middle Name
Mor George	Adi

Street Address 1	Street Address 2
15 Kafrisin St.

City	State/Province/Country	ZIP/Postal Code
Tel Aviv	ISRAEL	6901658

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name	First Name	Middle Name
Fatal	Sigal

Street Address 1	Street Address 2
16 Kanfey Nesharim St.

City	State/Province/Country	ZIP/Postal Code
Ramat Gan	ISRAEL	5235716

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name	First Name	Middle Name
Aharon	Arnon

Street Address 1	Street Address 2
12 Yavne St.

City	State/Province/Country	ZIP/Postal Code
Tel Aviv	ISRAEL	6579116

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name	First Name	Middle Name
Squinto	Stephen	P

Street Address 1	Street Address 2
930 5th Ave

City	State/Province/Country	ZIP/Postal Code
New York	NEW YORK	10021

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name	First Name	Middle Name
Alan	Moses	Charles

Street Address 1	Street Address 2
C/O CHEMOMAB THERAPEUTICS LTD.	Kiryat Atidim Building 7

City	State/Province/Country	ZIP/Postal Code
Tel Aviv	ISRAEL	6158002

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name	First Name	Middle Name
Nicaise	Claude

Street Address 1	Street Address 2
319 Redstone Drive

City	State/Province/Country	ZIP/Postal Code
Cheshire	CONNECTICUT	06410

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name	First Name	Middle Name
Darvish	Nissim

Street Address 1	Street Address 2
C/O CHEMOMAB THERAPEUTICS LTD.	KIRYAT ATIDIM, BUILDING 7

City	State/Province/Country	ZIP/Postal Code
Tel Aviv	ISRAEL	6158002

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name	First Name	Middle Name
Maryles	Joel	Michael

Street Address 1	Street Address 2
5 Atzmon St.

City	State/Province/Country	ZIP/Postal Code
Hashmonaim	ISRAEL	7312700

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

Last Name	First Name	Middle Name
Cohen	Neil	Harris

Street Address 1	Street Address 2
1400 E, STE 14-105	1 KENDALL SQ, BLDG

City	State/Province/Country	ZIP/Postal Code
Cambridge	MASSACHUSETTS	02139

Relationship:

Executive Officer

Director

Promoter

Clarification of Response (if Necessary)

4. Industry Group

o	Agriculture			Health Care		o	Retailing
	Banking & Financial Services			x	Biotechnology	o	Restaurants
	o	Commercial Banking		o	Health Insurance		Technology
	o	Insurance		o	Hospitals & Physicians		o	Computers
	o	Investing		o	Pharmaceuticals		o	Telecommunications
	o	Investment Banking		o	Other Health Care		o	Other Technology
	o	Pooled Investment Fund					Travel
	o	Other Banking & Financial Services	o	Manufacturing			o	Airlines & Airports
				Real Estate			o	Lodging & Conventions
				o	Commercial		o	Tourism & Travel Services
				o	Construction		o	Other Travel
				o	REITS & Finance	o	Other
				o	Residential
				o	Other Real Estate
o	Business Services
	Energy
	o	Coal Mining
	o	Electric Utilities
	o	Energy Conservation
	o	Environmental Services
	o	Oil & Gas
	o	Other Energy

5. Issuer Size

Revenue Range		Aggregate Net Asset Value Range
o	No Revenues	o	No Aggregate Net Asset Value
o	$1 - $1,000,000	o	$1 - $5,000,000
o	$1,000,001 - $5,000,000	o	$5,000,001 - $25,000,000
o	$5,000,001 - $25,000,000	o	$25,000,001 - $50,000,000
x	$25,000,001 - $100,000,000	o	$50,000,001 - $100,000,000
o	Over $100,000,000	o	Over $100,000,000
o	Decline to Disclose	o	Decline to Disclose
o	Not Applicable	o	Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

o	Rule 504(b)(1) (not (i), (ii) or (iii))	o	Rule 505
o	Rule 504 (b)(1)(i)	x	Rule 506(b)
o	Rule 504 (b)(1)(ii)	o	Rule 506(c)
o	Rule 504 (b)(1)(iii)	o	Securities Act Section 4(a)(5)
		o	Investment Company Act Section 3(c)

7. Type of Filing

New Notice

Date of First Sale

2021-03-16

First Sale Yet to Occur

Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?

Yes

9. Type(s) of Securities Offered (select all that apply)

o	Pooled Investment Fund Interests	x	Equity
o	Tenant-in-Common Securities	o	Debt
o	Mineral Property Securities	x	Option, Warrant or Other Right to Acquire Another Security
x	Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security	o	Other (describe)

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?	x	Yes	o	No

Clarification of Response (if Necessary)
The Issuer completed a business combination transaction on March 16, 2021, and as a condition thereto the Issuer consummated a private placement transaction, of which is being reported in this Form D.

11. Minimum Investment

Minimum investment accepted from any outside investor

$ 0 USD

12. Sales Compensation

Recipient			Recipient CRD Number	o	None
Oppenheimer & Co. Inc.			249
(Associated) Broker or Dealer	x	None	(Associated) Broker or Dealer CRD Number	x	None

Street Address 1			Street Address 2
85 BROAD STREET

City	State/Province/Country	ZIP/Postal Code
NEW YORK	NEW YORK	10004

State(s) of Solicitation	o	All States	o	Foreign/Non-US
CALIFORNIA CONNECTICUT ILLINOIS MARYLAND MASSACHUSETTS NEVADA NEW JERSEY NEW YORK OREGON TEXAS

13. Offering and Sales Amounts

Total Offering Amount	$ 45446544 USD	o Indefinite
Total Amount Sold	$ 45446544 USD
Total Remaining to be Sold	$ 0 USD	o Indefinite

Clarification of Response (if Necessary)

14. Investors

o	Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, Number of such non-accredited investors who already have invested in the offering
	Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:	26

15. Sales Commissions & Finders’ Fees Expenses

Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions	$ 1579794 USD	o	Estimate
Finders' Fees	$ 0 USD	o	Estimate

Clarification of Response (if Necessary)

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

$ 0 USD

Anchiano Therapeutics (NASDAQ:ANCN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024